{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:26:01Z","timestamp":1764602761764},"reference-count":74,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1157\/13073095","type":"journal-article","created":{"date-parts":[[2005,4,6]],"date-time":"2005-04-06T14:29:49Z","timestamp":1112797789000},"page":"240-249","source":"Crossref","is-referenced-by-count":9,"title":["Patolog\u00eda articular en la enfermedad inflamatoria intestinal"],"prefix":"10.1016","volume":"28","author":[{"given":"J.M.","family":"Paredes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Barrachina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Moreno-Osset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13073095_bib1","series-title":"Enfermedad inflamatoria intestinal (II)","first-page":"125","article-title":"Manifestaciones extraintestinales de la enfermedad inflamatoria intestinal","author":"L\u00f3pez San Rom\u00e1n","year":"2002"},{"key":"10.1157\/13073095_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004836-199607000-00009","article-title":"Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients","volume":"23","author":"Veloso","year":"1996","journal-title":"J Clin Gastroenterol"},{"key":"10.1157\/13073095_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00005792-197609000-00004","article-title":"The extraintestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients","volume":"55","author":"Greenstein","year":"1976","journal-title":"Medicine (Baltimore)"},{"key":"10.1157\/13073095_bib4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0889-857X(03)00043-7","article-title":"Enteropathic artritis","volume":"29","author":"Holden","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1157\/13073095_bib5","first-page":"373","article-title":"The artritis of ulcerative colitis: clinical and genetic aspects","volume":"19","author":"Scarpa","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1157\/13073095_bib6","doi-asserted-by":"crossref","first-page":"896","DOI":"10.7326\/0003-4819-136-12-200206180-00011","article-title":"Update on spondyloarthropathies","volume":"136","author":"Khan","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1157\/13073095_bib7","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","article-title":"The European Spondylarthropathy Study Group","volume":"34","author":"Dougados","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13073095_bib8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0889-857X(05)70042-9","article-title":"Bowel inflammation and the spondyloarthropathies","volume":"24","author":"De Keyser","year":"1998","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1157\/13073095_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gut.42.3.387","article-title":"Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history","volume":"42","author":"Orchard","year":"1998","journal-title":"Gut"},{"key":"10.1157\/13073095_bib10","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/003655201317097173","article-title":"Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients","volume":"36","author":"Salvarani","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"10.1157\/13073095_bib11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000171365","article-title":"Joint manifestations in gastrointestinal diseases. 1. Pathophysiological aspects, ulcerative colitis and Crohn's disease","volume":"10","author":"Gran","year":"1992","journal-title":"Dig Dis Sci"},{"key":"10.1157\/13073095_bib12","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/rheumatology\/40.11.1256","article-title":"The prevalence and incidence of peripheral artritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study)","volume":"40","author":"Palm","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1157\/13073095_bib13","first-page":"2860","article-title":"Spondyloarthropthy is underestimated in inflammatory bowel disease: prevalence and HLA asociation","volume":"27","author":"De Vlam","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1157\/13073095_bib14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"Van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13073095_bib15","first-page":"511","article-title":"Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study)","volume":"29","author":"Palm","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1157\/13073095_bib16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0899-7071(95)00046-S","article-title":"Asymptomatic sacroiliitis in inflammatory bowel disease. Assessment by computed tomography","volume":"19","author":"McEniff","year":"1995","journal-title":"Clin Imaging"},{"key":"10.1157\/13073095_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0720-048X(00)00243-6","article-title":"Enteropathic arthritis in the sacroiliac joint. Imaging and differential diagnosis","volume":"35","author":"Mester","year":"2000","journal-title":"Eur J Radiol"},{"key":"10.1157\/13073095_bib18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0889-8553(21)00215-6","article-title":"Extraintestinal considerations in IBD","volume":"24","author":"Levine","year":"1995","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1157\/13073095_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1026629528233","article-title":"Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis","volume":"44","author":"Das","year":"1999","journal-title":"Dig Dis Sci"},{"key":"10.1157\/13073095_bib20","first-page":"773","article-title":"Increased gut permeability in juvenile chronic arthritides. A multivariate analysis of the diagnostic parameters","volume":"18","author":"Picco","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1157\/13073095_bib21","first-page":"1241","article-title":"Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms","volume":"27","author":"Scarpa","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1157\/13073095_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/ard.44.4.239","article-title":"Circulating immune complexes containing secretory IgA in jejunoileal bypass disease","volume":"44","author":"Clegg","year":"1985","journal-title":"Ann Rheum Dis"},{"key":"10.1157\/13073095_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/rheumatology\/32.7.586","article-title":"Ileal pouch arthritis","volume":"32","author":"Axon","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1157\/13073095_bib24","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1053\/gast.2000.20173","article-title":"Identical T cell expansions in the colon mucosa and the synovium of a patient with enterogenic spondyloarthropathy","volume":"119","author":"May","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1157\/13073095_bib25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1053\/berh.2002.0249","article-title":"Ankylosing spondylitis and bowel disease","volume":"16","author":"Baeten","year":"2002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1157\/13073095_bib26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/path.1044","article-title":"Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy","volume":"196","author":"Baeten","year":"2002","journal-title":"J Pathol"},{"key":"10.1157\/13073095_bib27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0016-5085(00)70209-5","article-title":"Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease","volume":"118","author":"Orchard","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1157\/13073095_bib28","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/art.10329","article-title":"Role of NOD2 variants in spondylarthritis","volume":"46","author":"Crane","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13073095_bib29","first-page":"102","article-title":"Lack of association of ankylosing spondylitis with the most common NOD2 susceptibility alleles to Crohn's disease","volume":"30","author":"Ferreiros-Vidal","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1157\/13073095_bib30","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0016-5085(75)80270-8","article-title":"Clinical patterns in Crohn's disease: a statistical study of 615 cases","volume":"68","author":"Farmer","year":"1975","journal-title":"Gastroenterology"},{"key":"10.1157\/13073095_bib31","first-page":"743","article-title":"Erosive polyarthritis in Crohn's disease. Report of a case","volume":"66","author":"Benbouazza","year":"1999","journal-title":"Rev Rhum (engl. ed.)"},{"key":"10.1157\/13073095_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/ard.57.3.135","article-title":"Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis and reactive arthritis?","volume":"57","author":"Helliwell","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1157\/13073095_bib33","first-page":"703","article-title":"Arthritic manifestations of inflammatory bowel disease","volume":"83","author":"Gravallese","year":"1988","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13073095_bib34","first-page":"518","article-title":"Low back pain, sacroiliitis, and the relationship with HLA-B27 in Crohn's disease","volume":"30","author":"Steer","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1157\/13073095_bib35","first-page":"294","article-title":"HLA related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related artritis","volume":"12","author":"Mielants","year":"1985","journal-title":"J Rheumatol"},{"key":"10.1157\/13073095_bib36","first-page":"1491","article-title":"Macroscopic and microscopic lesions in seronegative spondyloarthropathies","volume":"17","author":"Simeon","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1157\/13073095_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/art.1780370105","article-title":"High frequency of silent inflammatory bowel disease in spondyloarthropathy","volume":"37","author":"Leirisalo-Repo","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13073095_bib38","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1053\/j.gastro.2003.08.035","article-title":"Subclinical intestinal inflammation and sacroiliac changes in relatives of patients with ankylosing spondylitis","volume":"125","author":"Bjarnason","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1157\/13073095_bib39","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/gut.28.4.394","article-title":"Histopathology of intestinal inflammation related to reactive artritis","volume":"28","author":"Cuvelier","year":"1987","journal-title":"Gut"},{"key":"10.1157\/13073095_bib40","first-page":"2266","article-title":"The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects","volume":"22","author":"Mielants","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1157\/13073095_bib41","first-page":"2273","article-title":"The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects","volume":"22","author":"Mielants","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1157\/13073095_bib42","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1053\/gast.1996.v110.pm8964393","article-title":"Long-term evolution of gut inflammation in patients with spondyloarthropathy","volume":"110","author":"De Vos","year":"1996","journal-title":"Gastroenterology"},{"issue":"Suppl 28","key":"10.1157\/13073095_bib43","first-page":"88","article-title":"Therapy of spondylarthropathy in inflammatory bowel disease","volume":"20","author":"Generi","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1157\/13073095_bib44","first-page":"228","article-title":"The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis. A randomized controlled trial","volume":"17","author":"Kraag","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1157\/13073095_bib45","first-page":"264","article-title":"Cost effectiveness of group physical therapy for ankylosing spondylitis. A randomized controlled trial","volume":"21","author":"Bakker","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1157\/13073095_bib46","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/gast.2000.9561","article-title":"Nonsteroidal anti-inflammatory drug gastropathy","volume":"119","author":"Hawkey","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1157\/13073095_bib47","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/0016-5085(93)90667-2","article-title":"Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine","volume":"104","author":"Bjarnason","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1157\/13073095_bib48","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/BF02235589","article-title":"Clinical, endoscopic, and histologic spectrum of nonsteroidal antiinflammatory drug-induced lesions in the colon","volume":"43","author":"Puspok","year":"2000","journal-title":"Dis Colon Rectum"},{"key":"10.1157\/13073095_bib49","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000199740","article-title":"Colonic inflammation and nonsteroidal anti-inflammatory drug administration. An assessment of the frecuency of the problem","volume":"41","author":"Tanner","year":"1988","journal-title":"Digestion"},{"key":"10.1157\/13073095_bib50","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/j.1572-0241.2000.02262.x","article-title":"Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study","volume":"95","author":"Felder","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13073095_bib51","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1111\/j.1572-0241.2000.02263.x","article-title":"Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease","volume":"95","author":"Bonner","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13073095_bib52","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1572-0241.2002.05608.x","article-title":"Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease","volume":"97","author":"Mahadevan","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13073095_bib53","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1365-2036.2003.01596.x","article-title":"An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease associated peripheral arthritis and arthralgia","volume":"17","author":"Reinisch","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13073095_bib54","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/bmj.290.6481.1535","article-title":"Wich component of sulphasalazine is active in rheumatoid artritis?","volume":"290","author":"Pullar","year":"1985","journal-title":"Br Med J"},{"key":"10.1157\/13073095_bib55","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/1529-0131(200112)44:12<2728::AID-ART459>3.0.CO;2-8","article-title":"Inflammatory bowel disease and spondyloarthropathy","volume":"44","author":"Smale","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13073095_bib56","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/bmj.293.6552.911","article-title":"Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients","volume":"293","author":"Dougados","year":"1986","journal-title":"Br Med J"},{"key":"10.1157\/13073095_bib57","first-page":"1111","article-title":"Sulphasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial","volume":"31","author":"Nissila","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13073095_bib58","first-page":"1482","article-title":"Meta-analysis of sulfasalazine in ankylosing spondylitis","volume":"17","author":"Ferraz","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1157\/13073095_bib59","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/rheumatology\/32.8.729","article-title":"The course of established ankylosing spondylitis and the effects of sulphasalazine over 3 years","volume":"32","author":"Kirwan","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1157\/13073095_bib60","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.1780380507","article-title":"Sulfasalazine in the teatment of spondyloarthropathy. A randomized, multicenter, doble-blind, placebo-controlled study","volume":"38","author":"Dougados","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13073095_bib61","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/art.1780391209","article-title":"Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study","volume":"39","author":"Clegg","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13073095_bib62","first-page":"714","article-title":"Clinical efficay of mesalamine in the treatment of the spondyloarthropathies","volume":"27","author":"Thomson","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1157\/13073095_bib63","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/gut.50.4.485","article-title":"The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30-year review","volume":"50","author":"Fraser","year":"2002","journal-title":"Gut"},{"key":"10.1157\/13073095_bib64","first-page":"1104","article-title":"Methotrexate in severe ankylosing spondylitis: an open study","volume":"22","author":"Creemers","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1157\/13073095_bib65","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/030097400750002021","article-title":"Methotrexate in the treatment of ankylosing spondylitis","volume":"29","author":"Sampaio-Barros","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1157\/13073095_bib66","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s100670050027","article-title":"Efficacy of methotrexate in the treatment of ankylosing spondylitis: a three-year open study","volume":"19","author":"Biasi","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1157\/13073095_bib67","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1440-1746.2002.02564.x","article-title":"Early studies on the safety and efficacy of thalidomide for symptomatic inflammatory bowel disease","volume":"17","author":"Bariol","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1157\/13073095_bib68","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.10396","article-title":"One-year open label trial of thalidomide in ankylosing spondylitis","volume":"3","author":"Huang","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13073095_bib69","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.4049\/jimmunol.161.8.4236","article-title":"CC-3052: a water soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha production","volume":"161","author":"Marriot","year":"1998","journal-title":"J Immunol"},{"key":"10.1157\/13073095_bib70","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/art.511","article-title":"Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis alpha (infliximab) versus placebo in active spondyloarthropathy","volume":"46","author":"Van den Bosch","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1157\/13073095_bib71","first-page":"2936","article-title":"Successful treatment of severe undifferentiate spondyloarthropathy with the anti-tumor necrosis factor a monoclonal antibody infliximab","volume":"44","author":"Brandt","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1157\/13073095_bib72","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/ard.59.6.428","article-title":"Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study","volume":"59","author":"Van den Bosch","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1157\/13073095_bib73","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0140-6736(00)03239-6","article-title":"Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptons","volume":"356","author":"Van den Bosch","year":"2000","journal-title":"Lancet"},{"key":"10.1157\/13073095_bib74","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1111\/j.1572-0241.2002.06064.x","article-title":"Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn's disease","volume":"97","author":"Herfarth","year":"2002","journal-title":"Am J Gastroenterol"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570505714527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570505714527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T21:05:27Z","timestamp":1683061527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570505714527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0210570505714527"],"URL":"https:\/\/doi.org\/10.1157\/13073095","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}